Myolyn
Gainesville, US · Founded 2013 · Florida LLC · 1 known investors
Find your way into Myolyn
Sign up to see every warm intro you have to Myolyn
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Myolyn team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MYOLYN develops Functional Electrical Stimulation (FES) technology that helps users activate muscles, build strength, and improve movement. Its systems serve people with paralysis, rehabilitation patients, active adults, and athletes across home, clinical, and training settings.
Founders & leadership
Myolyn was founded in 2013 by MATTHEW BELLMAN.

Investors · 1
Reported raises · per SEC filings
Form D private placements$1M disclosed across 2 of 3 rounds · 2015–2020
▶$202.5KraisedApr 2020 · 4 investors · Other TechnologyRule 506(b)
- Alan J. HamletExecutive Officer, Director
- Matthew BellmanDirector
- Offering amount
- $2M
- Amount sold
- $202.5K
- First sale
- Apr 2020
- Incorporated
- Limited Liability Company, Florida
- Federal exemptions
- 06b
▶$300KofferedMay 2017 · Other Health CareRule 506(b)
- ALAN J. HAMLETExecutive Officer, Director
- MATTHEW BELLMANExecutive Officer, Director
- Offering amount
- $300K
- Incorporated
- Limited Liability Company, Florida, 2013
- Federal exemptions
- 06b
▶$837.5KraisedMar 2017 · 6 investors · Other Health CareRule 506(b)
- ALAN J. HAMLETExecutive Officer, Director
- MATTHEW BELLMANExecutive Officer, Director
- Offering amount
- $1.3M
- Amount sold
- $837.5K
- Minimum investment
- $25K
- First sale
- May 2015
- Incorporated
- Limited Liability Company, Florida, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Myolyn.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2020 | $212.2K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Myolyn do?
- MYOLYN develops Functional Electrical Stimulation (FES) technology that helps users activate muscles, build strength, and improve movement. Its systems serve people with paralysis, rehabilitation patients, active adults, and athletes across home, clinical, and training settings.
- Who founded Myolyn?
- Myolyn was founded by MATTHEW BELLMAN in 2013.
- Who are Myolyn's investors?
- Myolyn's investors include Florida Technology Seed Capital Fund.
- How much funding has Myolyn raised?
- Myolyn has disclosed $1M raised across 2 of its 3 known rounds.
- Where is Myolyn headquartered?
- Myolyn is headquartered in Gainesville, US.

